01:39 PM EDT, 07/18/2025 (MT Newswires) -- Tevogen Bio ( TVGN ) said Friday that the World Intellectual Property Organization has released its international patent application for technology that leverages machine learning to forecast immunologically active peptides.

The patent document named "Systems and Methods for Predicting Immunologically Active Peptides with Machine Learning Models" discusses technology created by Tevogen.AI, which employs algorithms supported by Microsoft (MSFT) and Databricks to detect peptides that notably engage with the immune system, the company said.

The technology seeks to overcome the drawbacks of conventional peptide identification techniques by effectively evaluating potential peptides, discarding unviable options, and perpetually enhancing forecasts with real-world information, Tevogen said.

Shares of Tevogen Bio ( TVGN ) were up more than 4.8% in recent trading.

Price: 1.29, Change: +0.05, Percent Change: +4.03